The aim of our experiments was to produce a local T cell mediated immune response to gliadin in the mouse small intestine as a possible animal model of gluten sensitive enteropathy, coeliac disease. BALB/c and BDF, mice were immunised systemically with gliadin in complete Freund's adjuvant. The jejunal mucosa was challenged by feeding a gluten containing diet, and villus and crypt lengths, crypt cell production rate, and intraepithelial lymphocyte counts were determined to assess mucosal cell mediated immunity. In some animals permeability and local immunity were modulated by concurrent intestinal anaphylaxis or a graft versus host reaction. There were no changes in the jejunal mucosa of BALB/c mice fed a gluten containing diet after having been parenterally immunised. When, however, mice were parenterally immunised with gliadin, fed a gluten containing diet, rendered hypersensitive to helminth antigen by infection with the nematode parasite Nippostrongylus brasiliensis, and challenged intravenously to produce intestinal anaphylaxis crypt cell production rate was significantly higher than in ovalbumin immunised controls at 12 days after parasite challenge. Finally, graft versus host reaction was induced in BDFJ mice that had been parenterally immunised with gliadin and were on a gluten containing diet. Two weeks later these mice had significantly longer crypts and a higher crypt cell production rate and intraepithelial lymphocyte count than control, unimmunised mice with graft versus host reaction. We conclude that active immunisation with gliadin does not in itself produce intestinal cell mediated immunity to gliadin contained in the diet, or enteropathy. Additional factors, such as those occurring during intestinal anaphylaxis (increased intestinal permeability), or during graft versus host reaction (enhanced antigen presentation), seem to be necessary for the full expression of a jejunal mucosal reaction. In this series of experiments, our aim was to induce mucosal cell mediated immunity to gliadin in mice. Initially we used animals weaned and maintained on a gluten free diet. They were immunised systemically in order to prime for cell mediated immunity to gliadin, and a normal rodent gluten containing diet was used to deliver gluten to the gut of test animals. Indirect evidence of active mucosal cell mediated immunity was sought by measuring villus and crypt lengths and crypt cell production rate and by performing intraepithelial lymphocyte counts.
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Methods

ANIMALS AND DIETS
Female BALB/c mice were used, aged 6 to 10 weeks, unless otherwise stated. They were from a gluten free colony established in 1985 and maintained on a gluten free diet (Special Diet Service, Witham, Essex); only second or later generation mice were used for these experiments. Female BALB/c and (C57BL6/J x DBA2)F, (BDF,) mice were also used, maintained on a standard rodent diet which contains 2-8% gluten (CRM(X), Labsure, Poole, Dorset). This diet was also used for oral challenge with gliadin. There were six mice in each experimental group. 
Experiments and results
EFFECTS OF DIETARY GLUTEN ON UNPRIMED MICE
To assess the effect ofgluten contained in the diet on the mucosal architecture of our experimental mice, three different sets of observations were made. BALB/c mice weaned on a normal gluten containing diet or on a gluten free diet were compared seven days after weaning, at the age of 4 weeks; no differences were noted between the two groups in villus and crypt lengths and in crypt cell production rate. In a second experiment adult BALB/c mice on a normal gluten containing diet were used, and the effect of seven days of a gluten free diet on their intestinal architecture was evaluated; again, no change was observed in the parameters studied. Similarly, no differences were noted in adult BALB/c mice from a gluten free diet colony transferred for one or seven days to a diet containing gluten. The data are summarised in Table I In a further series ofexperiments we investigated whether, in addition to the induction of active cell mediated immunity to gliadin, other factors are necessary to allow the expression of a specific mucosal cell mediated immunity response in the gut. In the first of these the effect of intestinal anaphylaxis was evaluated. BALB/c mice were used and maintained throughout on gluten containing diet. They were given an intraperitoneal injection of gliadin in Freund's adjuvant and a boosting injection three weeks later; control animals were immunised with ovalbumin, an unrelated antigen not present in the diet of the mice. At the same time as the booster, both gliadin immunised and ovalbumin immunised animals were infected with Nippostrongylus braziliensis; 10 days later intestinal anaphylaxis was induced by the intravenous injection of Nippostrongylus antigens. Twelve days after anaphylaxis induction mice were sacrificed.
No differences were noted in villus and crypt lengths or in intraepithelial lymphocyte counts between ovalbumin and gliadin immunised mice, but the latter group showed a significantly higher crypt cell production rate (Fig 2) . These results support the hypothesis that the specific effector response by gliadin committed cells present in the mucosa is only made possible by changes in the local microenvironment. In this case increased mucosal permeability could play a crucial part by allowing the gliadin present in the diet to come in contact with sensitised cells in the mucosa.
EFFECTS OF GRAFT VERSUS HOST REACTION ON GLIADIN PRIMED MICE
In this experiment the mucosal immune state was modulated by the induction of a graft versus host reaction. BDF, mice were used, reared and maintained throughout on a gluten containing diet. They were given an intraperitoneal injection of gliadin in Freund's adjuvant and a boosting injection three weeks later. Control animals were immunised with ovalbumin. At the same time as the booster a graft versus host reaction was induced in both groups of mice; groups of animals were then sacrificed 7, 10, and 14 days later. At seven days there were no significant differences in villus length, crypt cell production rate, or intraepithelial lymphocyte counts between ovalbumin and gliadin immunised mice, but in the latter crypts were significantly longer. A similar pattern was observed 10 days after the induction of graft versus host reaction. After 14 days, gliadin immunised mice had longer crypts, a strikingly higher crypt cell production rate, and higher intraepithelial lymphocyte counts than controls, all of these differences being significant (Fig 3; Table II ).
Comment
The results of this experiment strongly suggest that antigen specific T cells, induced by parenteral immunisation, can, at least in the special circumstances of an evolving graft versus host reaction, reside within the gut mucosa and undergo activation. Under such conditions abnormal antigen processing and presentation may also be important factors, making possible the full expression ofa specific immune response.
Discussion
Coeliac disease has a strong link with certain HLA specificities: 95% of patients are HLADQw2 positive,6 and it is probably because of the crucial part played by immunogenetic factors that the disease is almost unique to humans. Wheat sensitive enteropathy has been described in Irish setter dogs7 and in monkeys,' but it is still unclear to what extent these animal diseases relate to human coeliac disease. An animal model, particularly in a species from which inbred strains are available, would be invaluable for investigating many facets of the pathogenesis and treatment of coeliac disease.
An animal model of gluten sensitive enteropathy should have as its main feature a gliadin induced intestinal mucosal lesion characterised by villus flattening, crypt hyperplasia, and dense infiltration of lymphocytes and other inflammatory cells within the epithelium and lamina propria. Similar changes, along with an increase in the proportion of goblet cells, brush border enzyme deficiency, and expression of class II antigens by crypt enterocytes, are features which have been described in allograft rejection, graft versus host reaction, and parasite infection, all of which are characterised by activation of T cell mediated immunity.9 This is the reason why, by analogy with these models, mucosal cell mediated immunity is thought to play a major part in the pathogenesis of the mucosal lesion in coeliac disease. The aim of the experiments described in this paper has been to produce an animal model ofgluten associated enteropathy in mice by inducing mucosal cell mediated immunity to gliadin. As there are no standard methods for detecting the presence of antigen specific effector cells in the mucosa, changes in the mucosal architecture have been used as indirect evidence of the presence of mucosal delayed type hypersensitivity.
Gliadin is a protein with peculiar physicochemical properties which make it different from other dietary antigens. In particular, a lectin like activity has been described.'0 Lectins may produce changes in the brush border membrane, damage to microvilli, and increased exfoliation of absorptive cells," and so preliminary experiments were necessary to define the effects of gluten on the mucosal architecture of adult unprimed mice. No differences were noted between mice weaned on a normal diet or on a gluten free diet; moreover, the withdrawal ofgluten from the diet ofmice reared on a normal gluten containing diet, or the introduction of gluten to the diet ofmice from the gluten free diet colony, did not produce any changes in mucosal architecture. A lectin like effect of dietary gluten was thus excluded.
As our aim was to produce an intestinal immune response to gliadin, it was first necessary to prime animals by active immunisation. Pre We have not yet produced villus flattening, a hallmark of the histology of coeliac disease. This may be a species specific problem, as in many other experiments we have found mice particularly resistant to villus damage. On the other hand, it is increasingly recognised that there is a continuous spectrum of histological changes in gluten sensitive enteropathy, ranging from an increase in villus intraepithelial lymphocyte count through crypt hypertrophy to the classical picture ofa flat coeliac mucosa.' It is possible that greater amounts of dietary gluten in our mice, or prolonging the time of gluten challenge, would lead to further progression of the histological lesion. Experiments along these lines are in progress.
Our experiments show that being primed to gliadin is not a sufficient condition for the development of a T cell mediated lesion of the intestine. Additional factors, such those occurring during intestinal anaphylaxis or graft versus host reaction, are necessary. These observations support the two stage model of coeliac disease, '7 which is based on the postulate that 'latent' gluten sensitive enteropathy is a fairly common condition which requires a second insult to allow the evolution of gluten induced intestinal damage and malabsorption. Latent coeliac disese was first reported by Weinstein'8 and has been shown to occur in patients with dermatitis herpetiformis and in first degree relatives of coeliac patients, some of whom have minor histological abnormalities of the jejunal mucosa while on a normal gluten containing diet.920 Analogous to what we have observed in mice, it is conceivable that some coeliac patients have in the first instance altered immunity to gliadin -for example, high titres of serum or secretory antibodies -probably on a genetic basis. Additional non-genetic factors then precipitate the full blown disease, possibly by perturbing the local immune system. Clinically overt coeliac disease is occasionally precipitated by factors such as radical changes in diet, upper gastrointestinal surgery, gastroenteritis, or pregnancy.2' The previous state will often have been merely silent, subclinical coeliac disease, but there may be a few patients who are the clinical analogues of our experimental model in whom environmental factors have converted latent disease to fully expressed enteropathy.
